CYTH - Cyclo Therapeutics, Inc.

QQQ $ 452.83 $ 6.97 (1.56 %)

DIA $ 399.31 $ 3.70 (0.94 %)

SPY $ 529.09 $ 6.48 (1.24 %)

TLT $ 92.14 $ 1.24 (1.36 %)

GLD $ 220.89 $ 2.80 (1.28 %)

Previous Close

$ 1.43

Open

$ 1.53

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.42 - $ 1.53

52 Week Range

$ 0.89 - $ 2.57

Volume

16,340

Average Volume

Market Cap

40.92M

Beta (5Y Monthly)

$ -0.18

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-15-2024	03-31-2024	10-Q
2	03-18-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-12-2023	03-31-2023	10-Q
6	03-17-2023	12-31-2022	10-K
7	11-10-2022	09-30-2022	10-Q
8	08-15-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-11-2022	12-31-2021	10-K
11	11-15-2021	09-30-2021	10-Q
12	08-16-2021	06-30-2021	10-Q
13	05-14-2021	03-31-2021	10-Q
14	03-12-2021	12-31-2020	10-K
15	11-12-2020	09-30-2020	10-Q
16	08-14-2020	06-30-2020	10-Q
17	05-15-2020	03-31-2020	10-Q
18	03-30-2020	12-31-2019	10-K
19	11-14-2019	09-30-2019	10-Q
20	08-13-2019	06-30-2019	10-Q
21	05-15-2019	03-31-2019	10-Q
22	03-15-2019	12-31-2018	10-K
23	11-09-2018	09-30-2018	10-Q
24	08-14-2018	06-30-2018	10-Q
25	05-15-2018	03-31-2018	10-Q
26	04-16-2018	12-31-2017	10-K
27	11-09-2017	09-30-2017	10-Q
28	08-11-2017	06-30-2017	10-Q
29	05-12-2017	03-31-2017	10-Q
30	03-17-2017	12-31-2016	10-K
31	11-10-2016	09-30-2016	10-Q
32	08-12-2016	06-30-2016	10-Q
33	05-16-2016	03-31-2016	10-Q
34	03-30-2016	12-31-2015	10-K
35	11-12-2015	09-30-2015	10-Q
36	08-14-2015	06-30-2015	10-Q
37	05-15-2015	03-31-2015	10-Q
38	03-27-2015	12-31-2014	10-K
39	11-14-2014	09-30-2014	10-Q
40	08-14-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Initiates Coverage On ...
05/01/2024 10:13:28

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Cyclo Therapeutics (NASDAQ:CYTH) with a Buy rat...

Ascendiant Capital Initiates Coverage On C...
04/22/2024 09:40:07

Ascendiant Capital analyst Lucas Ward initiates coverage on Cyclo Therapeutics (NASDAQ:CYTH) with a Buy rating and announces...

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
04/18/2024 20:31:32

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
04/02/2024 20:31:04

Cyclo Therapeutics Receives Decision To Gr...
04/02/2024 18:31:50

https://register.epo.org/application?number=EP19805439

Cyclo Therapeutics FY23 EPS $(1.23) Up Fro...
03/18/2024 13:11:41

Cyclo Therapeutics Announces Issuance Of U...
03/14/2024 13:35:58

Cyclo Therapeutics, Inc. (NASDAQ:CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology ...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
03/13/2024 21:32:47

Cyclo Therapeutics Announces Allowance Of ...
01/29/2024 14:15:51

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
01/15/2024 17:30:51

why-douyu-international-shares-are-trading-higher-by-14-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why DouYu International Shares Are Trading...
12/28/2023 18:07:18

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share ...

why-bridgeline-digital-shares-are-trading-lower-by-13-here-are-20-stocks-moving-premarket

Why Bridgeline Digital Shares Are Trading ...
12/28/2023 13:22:02

Shares of Bridgeline Digital, Inc. (NASDAQ: BLIN) fell sharply in pre-market following the release of fourth-quarter results. ...

12 Health Care Stocks Moving In Wednesday'...
12/27/2023 21:31:03

Cyclo Therapeutics, Announced Outcome From...
12/18/2023 14:20:41

Ongoing pivotal Phase 3 study ("TransportNPC™") evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease T...

Cyclo Therapeutics Q3 EPS $(0.29) Up From ...
11/15/2023 13:23:17

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.29) per share. This is a 42 percent increase over losses of $...

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
11/08/2023 17:31:09

Cyclo Therapeutics Has Received A Notice O...
11/06/2023 17:14:33

https://patentcenter.uspto.gov/applications/17289137/ifw/docs

Cyclo Therapeutics Announces Early Exercis...
10/23/2023 12:18:52

Issues New Warrants to this Investment Group for Possible Additional Funding of Up to $3.47 Million (if exercised) Cyclo Thera...

Benzinga's Top Ratings Upgrades, Downgrade...
09/27/2023 15:00:45

Maxim Group Upgrades Cyclo Therapeutics to...
09/27/2023 13:35:12

Maxim Group analyst Jason McCarthy upgrades Cyclo Therapeutics (NASDAQ:CYTH) from Hold to Buy and announces $4 price target.